1. B.K. Immel, A brief history of the GMPs for Pharmaceuticals, Pharm. Technol.,
2. July 2001, 44-52 (2001).
3. J. Tatarkiewicz, M.J. Bujalska-Zadrozny, The antihypertensive drugs and contamination
4. with carcinogenic nitrosamines, Folia Cardiol., 14(6), 564-571 (2019).
5. United States Food and Drug Administration. Statement alerting patients and